Clinical trials for a new treatment for skin cancer are in phase 3 with promising results. The treatment called TIL uses tumor-penetrating lymphocytes from the person’s own white cells, which can recognize and break the tumor. Tumors in half of the patients in the trials shrank, and in fifth of the patients they disappeared completely.
Photo by: https://www.flickr.com/photos/nihgov/20496714399
